"The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.
Ogen Patient Information including How Should I Take
In this Article
- What is estropipate (Ogen)?
- What are the possible side effects of estropipate (Ogen)?
- What is the most important information I should know about estropipate (Ogen)?
- What should I discuss with my health care provider before using estropipate (Ogen)?
- How should I use estropipate (Ogen)?
- What happens if I miss a dose (Ogen)?
- What happens if I overdose (Ogen)?
- What should I avoid while using estropipate (Ogen)?
- What other drugs will affect estropipate (Ogen)?
- Where can I get more information?
What should I discuss with my health care provider before using estropipate (Ogen)?
Do not use estropipate if you have:
- a bleeding or blood-clotting disorder;
- a history of stroke or circulation problems;
- abnormal vaginal bleeding that a doctor has not checked; or
- any type of breast, uterine, or hormone-dependent cancer.
Before using estropipate, tell your doctor if you have:
- high blood pressure, angina, or heart disease;
- high cholesterol or triglycerides;
- liver disease;
- kidney disease;
- epilepsy or other seizure disorder;
- gallbladder disease; or
- if you have had your uterus removed (hysterectomy).
If you have any of these conditions, you may not be able to use estropipate, or you may need a dosage adjustment or special tests during treatment.
Estropipate increases your risk of developing endometrial hyperplasia, a condition that may lead to cancer of the uterus. Taking progestins while using estropipate may lower this risk. If your uterus has not been removed, your doctor may prescribe a progestin for you to take while you are using estropipate.
Long-term estropipate treatment may increase your risk of stroke. Talk with your doctor about your individual risks before using estropipate long-term. Your doctor should check your progress on a regular basis (every 3 to 6 months) to determine whether you should continue this treatment.
FDA pregnancy category X. This medication can cause birth defects. Do not use estropipate if you are pregnant. Tell your doctor right away if you become pregnant during treatment. Use an effective form of birth control while you are using this medication.
Estropipate can pass into breast milk and may harm a nursing baby. This medication may also slow breast milk production. Do not use if you are breast-feeding a baby.
How should I use estropipate (Ogen)?
Use this medication exactly as it was prescribed for you. Do not use the medication in larger amounts, or use it for longer than recommended by your doctor. Follow the directions on your prescription label.
Take this medication with a full glass of water.
You may take estropipate with food or after a meal to reduce stomach upset.
Have regular physical exams and self-examine your breasts for lumps on a monthly basis while using estropipate.
Store this medication at room temperature away from moisture and heat.
Additional Ogen Information
- Ogen Drug Interactions Center: estropipate oral
- Ogen Side Effects Center
- Ogen Overview including Precautions
- Ogen FDA Approved Prescribing Information including Dosage
Ogen - User Reviews
Ogen User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.